Sign in

CIK 0001070494

  • Large accelerated filer

ACADIA PHARMACEUTICALS INC

Sign in to watch
Ticker
ACAD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
061376651
Phone
+1 858-558-2871
Business address
12830 EL CAMINO REAL, SUITE 400, SAN DIEGO, CA, 92130
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Open-market sale Director sold 4,450 shares at $20.52 ($91,336)
  7. 4 Open-market sale Director sold 32,857 shares at $20.03 ($658,234)
  8. 4 Open-market sale CEO sold 25,000 shares at $17.75 ($443,835)
  9. 4 Open-market sale Director sold 14,285 shares at $22.54 ($321,925)
  10. 4 Open-market sale Director sold 30,000 shares at $21.98 ($659,385)
  11. 4 Open-market sale EXEC VP, CFO AND CBO sold 15,000 shares at $22.48 ($337,260)
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Open-market buy Director bought 526,316 shares at $28.50 ($15,000,006)
  17. 4 Open-market sale VP AND GC sold 42,000 shares at $30.28 ($1,271,718)
  18. 4 Open-market sale CEO sold 25,000 shares at $24.14 ($603,528)
  19. 4 Open-market sale Director sold 10,000 shares at $24.18 ($241,764)
  20. 4 Open-market sale CEO sold 25,000 shares at $24.01 ($600,288)

Page 22 of 35 · 686 filings